MY148300A - Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative - Google Patents

Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative

Info

Publication number
MY148300A
MY148300A MYPI20072165A MY148300A MY 148300 A MY148300 A MY 148300A MY PI20072165 A MYPI20072165 A MY PI20072165A MY 148300 A MY148300 A MY 148300A
Authority
MY
Malaysia
Prior art keywords
pyrazolopyrimidinone derivative
prevention
treatment
liver diseases
present
Prior art date
Application number
Inventor
Choi Seul Min
Ahn Byoung Ok
Yoo Moohi
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Priority to MYPI20072165 priority Critical patent/MY148300A/en
Publication of MY148300A publication Critical patent/MY148300A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO THE PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF LIVER DISEASES CONTAINING PYRAZOLOPYRIMIDINONE DERIVATIVE AS AN ACTIVE INGREDIENT. ACCORDING TO THE PRESENT INVENTION, PYRAZOLOPYRIMIDINONE DERIVATIVE HAS AN EXCELLENT EFFECT ON INHIBITING COLLAGEN SYNTHESIS IN HEPATIC STELLATE CELLS AND ACTS DIRECTLY ON THE PORTAL VEIN. PARTICULARLY, IT MAY INCREASE THE DIAMETER AND THE AMOUNT OF BLOOD FLOW OF THE PORTAL VEIN, AND FINALLY DECREASE THE PRESSURE THEREOF. THEREFORE, PYRAZOLOPYRIMIDINONE DERIVATIVE CAN BE USED ADVANTAGEOUSLY FOR PREVENTION AND TREATMENT OF HEPATIC FIBROSIS, LIVER CIRRHOSIS CAUSED BY HEPATIC FIBROSIS, PORTAL HYPERTENSION AND VARIOUS COMPLICATIONS CAUSED BY PORTAL HYPERTENSION. IN ADDITION, PYRAZOLOPYRIMIDINONE DERIVATIVE ACCORDING TO THE PRESENT INVENTION CAN REDUCE DOSING FREQUENCY BECAUSE OF ITS LONG HALF-LIFE, AND THEREFORE, HAS AN ADVANTAGE TO IMPROVE THE DRUG COMPLIANCE OF PATIENTS SUFFERING FROM CHRONICAL LIVER DISEASES.
MYPI20072165 2007-12-04 2007-12-04 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative MY148300A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20072165 MY148300A (en) 2007-12-04 2007-12-04 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20072165 MY148300A (en) 2007-12-04 2007-12-04 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative

Publications (1)

Publication Number Publication Date
MY148300A true MY148300A (en) 2013-03-29

Family

ID=50276841

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20072165 MY148300A (en) 2007-12-04 2007-12-04 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative

Country Status (1)

Country Link
MY (1) MY148300A (en)

Similar Documents

Publication Publication Date Title
ZA200800180B (en) Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative
EA200870216A1 (en) AMIDO COMPOUNDS AND THEIR APPLICATION AS MEDICINES
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20075136L (en) New liposome preparations
DE602006014990D1 (en) INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN
EA200901319A1 (en) COMPOSITIONS FOR BOTTOM INTRODUCTION
WO2007144327A3 (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
NZ588913A (en) Liver cancer drug
EA200501203A1 (en) LIQUID PHARMACEUTICAL COMPOSITIONS OF PALONOSETRON
ATE470443T1 (en) INDOL-1-YL ACID DERIVATIVES
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
MY163762A (en) Therapeutic agent for chronic renal failure
MX2009005798A (en) Stroke recovery.
WO2008114376A1 (en) Melanogenesis inhibitory composition
WO2009120885A3 (en) Stabilizing lipid compositions for oral pharmaceutical agents
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
UY30126A1 (en) A NEW PHARMACEUTICALLY ACCEPTABLE SALT OF 2-HIDROXI-3- (5- (MORFOLIN-4-ILMETIL) -PIRIDIN-2-L) 1H-INDOL-5-CARBONITRILE, PROCEDURES FOR THE PREPARATION, COMPOSITIONS CONTAINING IT AND APPLICATIONS
WO2007056236A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
IL191670A0 (en) Compounds for the inhibition of apoptosis
MY148300A (en) Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative
WO2009043577A3 (en) Contraceptive 19-nor progesterones
SE0203817D0 (en) New composition
WO2008005806A3 (en) Therapeutic methods, compositions, and compounds
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof